90 related articles for article (PubMed ID: 8928197)
1. Expression of Ki-67 by monoclonal antibody MIB-1 in carcinoma of the middle and lower bile duct.
Yamada Y; Yamauchi H; Kakizaki K; Suzuki H
Tohoku J Exp Med; 1995 Dec; 177(4):375-7. PubMed ID: 8928197
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K
Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of p53 and Ki-67 expression in resected or biopsy specimens of bile duct carcinoma.
Murakami M; Sasaki T; Kuwada Y; Yamasaki S; Kuwahara K; Chayama K
Oncol Rep; 2003; 10(5):1091-6. PubMed ID: 12883663
[TBL] [Abstract][Full Text] [Related]
4. Expression and Significance of COX-2 and Ki-67 in Hepatolithiasis with Bile Duct Carcinoma.
Wang P; He Y; Ma X; Sun B; Huang B; Zhu C; Liu Y
Med Sci Monit; 2015 Oct; 21():2943-9. PubMed ID: 26423666
[TBL] [Abstract][Full Text] [Related]
5. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
Lee CS
Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies.
Markiewski M; Domagała W
Pol J Pathol; 1996; 47(4):189-94. PubMed ID: 9097711
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of cell proliferation (Ki-67 antigen) and nuclear DNA content in clinically resectable, distal bile duct carcinoma.
Rijken AM; Umezawa A; van Gulik TM; Bosma A; Polak MM; Offerhaus GJ; Obertop H; Gouma DJ
Ann Surg Oncol; 1998 Dec; 5(8):699-705. PubMed ID: 9869516
[TBL] [Abstract][Full Text] [Related]
8. Relationship between AgNORs, MIB-1 and oncogene expression in male breast carcinoma and papillary superficial bladder neoplasm.
Pich A; Margaria E; Chiusa L; Bortolin P; Palestro G
Oncol Rep; 2003; 10(5):1329-35. PubMed ID: 12883702
[TBL] [Abstract][Full Text] [Related]
9. Comparative prognostic value of Ki-67 and MIB-1 proliferation indices in breast cancer.
Veronese SM; Maisano C; Scibilia J
Anticancer Res; 1995; 15(6B):2717-22. PubMed ID: 8669852
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV
APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232
[TBL] [Abstract][Full Text] [Related]
11. Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy.
Bettencourt MC; Bauer JJ; Sesterhenn IA; Mostofi FK; McLeod DG; Moul JW
J Urol; 1996 Sep; 156(3):1064-8. PubMed ID: 8709308
[TBL] [Abstract][Full Text] [Related]
12. [Detection of Ki-67 in liver biopsy specimens using monoclonal antibody to Mib-1].
Matsumoto K; Tanimoto K; Michitaka K; Furutani T; Nakaya M; Horiike N; Onji M
Rinsho Byori; 1999 Oct; 47(10):956-60. PubMed ID: 10590670
[TBL] [Abstract][Full Text] [Related]
13. Prognosis in malignant mesothelioma related to MIB 1 proliferation index and histological subtype.
Beer TW; Buchanan R; Matthews AW; Stradling R; Pullinger N; Pethybridge RJ
Hum Pathol; 1998 Mar; 29(3):246-51. PubMed ID: 9496827
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of different members of the type 1 growth factor receptor family and their association with cell proliferation in periampullary carcinoma.
Vaidya P; Kawarada Y; Higashiguchi T; Yoshida T; Sakakura T; Yatani R
J Pathol; 1996 Feb; 178(2):140-5. PubMed ID: 8683379
[TBL] [Abstract][Full Text] [Related]
15. IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas.
Riener MO; Fritzsche FR; Clavien PA; Pestalozzi BC; Probst-Hensch N; Jochum W; Kristiansen G
Hum Pathol; 2009 Oct; 40(10):1377-83. PubMed ID: 19467694
[TBL] [Abstract][Full Text] [Related]
16. Proliferative, infiltrative, and metastatic activities in colorectal tumors assessed by MIB-1 antibody.
Ishida H; Sadahiro S; Suzuki T; Ishikawa K; Kamijo A; Tajima T; Makuuchi H; Murayama C
Oncol Rep; 2003; 10(6):1741-5. PubMed ID: 14534689
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive and minimally invasive papillary carcinomas of the extrahepatic bile ducts.
Albores-Saavedra J; Murakata L; Krueger JE; Henson DE
Cancer; 2000 Aug; 89(3):508-15. PubMed ID: 10931449
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus.
Youssef EM; Matsuda T; Takada N; Osugi H; Higashino M; Kinoshita H; Watanabe T; Katsura Y; Wanibuchi H; Fukushima S
Cancer; 1995 Aug; 76(3):358-66. PubMed ID: 8625114
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features of "intraductal papillary neoplasm of the bile duct" and patient outcome after surgical resection.
Nanashima A; Kinoshita N; Nakanuma Y; Zen Y; Sumida Y; Abo T; Hidaka S; Takeshita H; Yasutake T; Hayashi T; Nagayasu T
Hepatogastroenterology; 2008; 55(85):1167-73. PubMed ID: 18795651
[TBL] [Abstract][Full Text] [Related]
20. The relationship between MIB-1 proliferation index and outcome in pancreatic neuroendocrine tumors.
Gentil Perret A; Mosnier JF; Buono JP; Berthelot P; Chipponi J; Balique JG; Cuilleret J; Dechelotte P; Boucheron S
Am J Clin Pathol; 1998 Mar; 109(3):286-93. PubMed ID: 9495200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
